Goto H, Kushihashi T, Benson K T, Kato H, Fox D K, Arakawa K
Anesth Analg. 1985 Nov;64(11):1081-4.
The possibility that hypotension associated with protamine or heparin might be related to changes in levels of serum ionized calcium values was determined by in vitro and in vivo studies in dogs. In vitro protamine did not decrease serum calcium levels, but heparin did in a dose-dependent fashion. The reduction ranged from 7% with 10 units/ml of heparin to 20% with 100 units/ml of heparin. Ionized calcium concentrations initially decreased by heparin were restored toward control levels by our increasing the dose of protamine, indicating that the electrostatic attraction between protamine and heparin molecules is stronger than that between heparin and ionized calcium. Despite significant reductions in blood pressure and heart rate, clinical doses of protamine did not decrease ionized calcium in vivo. Although the results of the in vitro study suggested that heparin-induced hypocalcemia might occur in vivo, in vivo heparin caused neither a decrease in ionized calcium nor hypotension. The reduction of ionized calcium by heparin might have been rapidly compensated for in vivo. The results indicate that hypotension due to protamine or heparin is unlikely to be related to changes in serum ionized calcium levels.
通过对犬类进行的体外和体内研究,确定了与鱼精蛋白或肝素相关的低血压可能与血清离子钙水平变化有关。体外实验中,鱼精蛋白不会降低血清钙水平,但肝素会以剂量依赖的方式降低血清钙水平。降低幅度从每毫升10单位肝素时的7%到每毫升100单位肝素时的20%不等。肝素最初降低的离子钙浓度通过增加鱼精蛋白剂量恢复至对照水平,这表明鱼精蛋白与肝素分子之间的静电吸引力强于肝素与离子钙之间的静电吸引力。尽管血压和心率显著降低,但临床剂量的鱼精蛋白在体内并未降低离子钙水平。虽然体外研究结果提示肝素诱导的低钙血症可能在体内发生,但体内肝素既未导致离子钙降低,也未引起低血压。肝素导致的离子钙降低可能在体内迅速得到了代偿。结果表明,鱼精蛋白或肝素所致的低血压不太可能与血清离子钙水平变化有关。